Author:
Xu Yuting,Xie Shudong,Zhou Chengyu,Zhu Liping,Tong Yao,Munoz Alvaro,Wu Yuhang,Li Xuhong
Abstract
AbstractTesticular cancer (TCa) is a rare but impactful malignancy that primarily affects young men. Understanding the mortality rate of TCa is crucial for improving prevention and treatment strategies to reduce the risk of death among patients. We obtained TCa mortality data by place (5 countries), age (20–79 years), and year (1990–2019) from the Global Burden of Disease Study 2019. Age-period-cohort model was used to estimate the net drift, local drift, age effects, period and cohort effects. In 2019, the global mortality of TCa increased to 10842 (95% UI 9961, 11902), with an increase of 50.08% compared to 1990.The all-age mortality rate for TCa in 2019 increased from 0.17/100,000 (95% UI 0.13, 0.20) in China to 0.48/100,000 (95% UI 0.38, 0.59) in Russian Federation, whereas the age-standardized mortality rate in 2019 was highest in the South Africa 0.47/100,000 (95% UI 0.42, 0.53) and lowest in the China 0.16/100,000 (95% UI 0.13, 0.19). China's aging population shifts mortality patterns towards the elderly, while in Russian Federation, young individuals are primarily affected by the distribution of deaths. To address divergent TCa mortality advancements in BRICS countries, we propose a contextually adaptive and resource-conscious approach to prioritize TCa prevention. Tailoring strategies to contextual diversity, including policy frameworks, human resources, and financial capacities, will enhance targeted interventions and effectiveness in reducing TCa mortality.
Funder
the Key Research and Development Program of the Hunan Provincial Science and Technology Department
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Gaddam, S. J. & Chesnut, G. T. Testicle Cancer (Treasure Island, 2023).
2. Cassell, A. et al. Review of testicular tumor: Diagnostic approach and management outcome in Africa. Res. Rep. Urol. 12, 35–42 (2020).
3. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA Cancer J. Clin. 68, 7–30 (2018).
4. Ghazarian, A. A., Kelly, S. P., Altekruse, S. F., Rosenberg, P. S. & McGlynn, K. A. Future of testicular germ cell tumor incidence in the United States: Forecast through 2026. Cancer 123, 2320–2328 (2017).
5. Park, J. S., Kim, J., Elghiaty, A. & Ham, W. S. Recent global trends in testicular cancer incidence and mortality. Medicine (Baltimore) 97, e12390 (2018).